Journal of Clinical Trials
Open Access
ISSN: 2167-0870
ISSN: 2167-0870
Molecular Diagnostic Laboratory of Cancer Center, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Dr. Yu-Lan Wang is currently working in Molecular Diagnostic Laboratory of Cancer Center, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. He has published numerous research papers and articles in reputed journals and has various other achievements in the related studies. He has extended his valuable service towards the scientific community with his extensive research work.
Research Article
Risk Factors and a Prognostic Scoring System for Severe Disease in Patients with COVID-19: A Retrospective Cohort Study
Author(s): Sen Yang, Le Ma, Yu-Lan Wang, Qiang Tong, De-Hua Yu, Sheng-Ming Dai and Ran Cui*
Background: The corona virus disease 2019 (COVID-19) has made a big threat on the global public health. The aim
of the study is to comprehensively explore the risk factor for severe disease events (intensive care, invasive ventilation,
or death) in patients with COVID-19, and to establish a prognostic scoring system.
Methods: Patients with laboratory-confirmed COVID-19 admitted to the Wuhan Leishenshan Hospital from
February 13 to March 14, 2020, was retrospectively analyzed. Demographic data, symptoms, laboratory values at
baseline, comorbidities, treatments and clinical outcomes were extracted. The LASSO and multivariate logistic regression models were developed to explore the risk factors for critical-ill events. A risk model was established via nomogram.
Results: 463 COVID-19 patients were in.. View More»
DOI:
10.35248/2167-0870.21.11.470